Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung × sacituzumab govitecan × 1 year × Clear all

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06431633 2026-05-18

ARIAN

Phase 3 Recruiting

129 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Diseases

NCT03337698 2026-05-12

Morpheus Lung

Phase 1/2 Terminated

314 enrolled 31 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05089734 2026-05-07

EVOKE-01

Phase 3 Active not recruiting

603 enrolled 20 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07438600 2026-03-27

TianjinCIH

Phase 2 Not yet recruiting

38 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05186974 2026-02-11

EVOKE-02

Phase 2 Active not recruiting

193 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07393555 2026-02-06

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

Phase 2 Not yet recruiting

117 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05609968 2025-12-24

MK-3475-D46

Phase 3 Active not recruiting

614 enrolled

Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

Clinical Trials

VELOCITY-Lung

ARIAN

Morpheus Lung

EVOKE-01

TianjinCIH

EVOKE-02

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

MK-3475-D46